MAPT and Alzheimer disease: Hyperglycemia and insulin resistance accelerate brain damage in AD by inducing production and accumulation of amyloid β as well as enhancing hyperphosphorylation of tau protein [40], thus exacerbating the course of AD and its symptoms.